Jul 14, 2025, 12:32
Anticoagulation in Liver Transplant Candidates: Is Apixaban Safe?
The American Journal of Transplantation shared a post on X:
”Up to 26% of liver transplant candidates have an indication for anticoagulation whilst on the waiting list. Apixaban appears safe to use in the peri-transplant setting for low MELD patients awaiting liver transplantation.”
Title: Safety of apixaban prior to liver transplantation: A single-center Australian case-control study in a population with low scores on the model for end-stage liver disease
Authors: Katrina Tan, Zoe Yang, Elizabeth Low, Jordi Shahab, Jacqueline Balassone, Graham Starkey, Marcos Perini, Lachlan Miles, Adam Testro, Marie Sinclair, Avik Majumdar
Read the full article here.
Stay informed with Hemostasis Today.
-
Apr 7, 2026, 19:17Anand Padmanabhan: Persistence and Pathogenicity of Platelet Factor 4 Antibodies in VITT
-
Apr 7, 2026, 19:07Clara Meijs: Great Time Presenting Our Endometriosis Project at the AHA EPI Lifestyle Conference
-
Apr 7, 2026, 18:18Vivek Das: How Obesity, Type 2 Diabetes, and Dyslipidaemia Interact Across Multiple Cardiovascular Conditions
-
Apr 7, 2026, 17:44Augustina Isioma Ikusemoro: Quality Indicators for Red Blood Cells in Transfusion Medicine
-
Apr 7, 2026, 17:35Nikola Grubor: In Situ Pulmonary Arterial Thrombosis Mimicking CTEPH in Eisenmenger
-
Apr 7, 2026, 17:34Pooja Choradia: vWF Breakdown in Aortic Stenosis – Anaemia and Pulmonary Relevance
-
Apr 7, 2026, 17:32Wolfgang Miesbach: Exceptional Presentation on the Role of vWF in Angiogenesis and Gut Angiodysplasia in VWD
-
Apr 7, 2026, 17:30Chokri Ben Lamine: No Routine VTE Prophylaxis for Chronically Bedridden Patients at Home
-
Apr 7, 2026, 17:28Amanda Johnson: The Stretch of Science in the History of EDS